Regulation and prognostic relevance of symmetric dimethylarginine serum concentrations in critical illness and sepsis

Mediators of Inflammation

Volumn 2013, Issue , 2013, Pages

  Koch, Alexander ^a   Weiskirchen, Ralf ^a   Bruensing, Jan ^a   Dückers, Hanna ^a   Buendgens, Lukas ^a   Kunze, Julian ^a   Matthes, Michael ^a   Luedde, Tom ^a   Trautwein, Christian ^a   Tacke, Frank ^a  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 N,N' DIMETHYLARGININE; BILIRUBIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLINESTERASE; N(G),N(G) DIMETHYLARGININE; PROCALCITONIN; TUMOR NECROSIS FACTOR; UROKINASE RECEPTOR; ARGININE; N,N'-DIMETHYLARGININE; DRUG DERIVATIVE; N,N' DIMETHYLARGININE;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; KIDNEY FAILURE; LEUKOCYTE COUNT; LIVER FAILURE; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REGULATORY MECHANISM; SEPSIS; SEPTIC SHOCK; ADOLESCENT; ANALOGS AND DERIVATIVES; BLOOD; GENE EXPRESSION REGULATION; INFLAMMATION; INTENSIVE CARE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; PATHOLOGY; REGRESSION ANALYSIS; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ARGININE; BIOLOGICAL MARKERS; CRITICAL ILLNESS; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INFLAMMATION; INTENSIVE CARE; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; MULTIVARIATE ANALYSIS; PROGNOSIS; REGRESSION ANALYSIS; RISK FACTORS; SEPSIS; YOUNG ADULT;

EID: 84880145962     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2013/413826     Document Type: Article

References (25)

1. De Backer D., Creteur J., Preiser J.-C., Dubois M.-J., Vincent J.-L., Microvascular blood flow is altered in patients with sepsis. American Journal of Respiratory and Critical Care Medicine 2002 166 1 98 104 2-s2.0-0036644655 10.1164/rccm.200109-016OC (Pubitemid 34693970)
2. De Backer D., Donadello K., Sakr Y., Ospina-Tascon G., Salgado D., Scolletta S., Vincent J. L., Microcirculatory alterations in patients with severe sepsis: impact of time of assessment and relationship with outcome. Critical Care Medicine 2013 41 791 799
3. Donati A., Domizi R., Damiani E., Adrario E., Pelaia P., Ince C., From macrohemodynamic to the microcirculation. Critical Care Research and Practice 2013 2013 8 10.1155/2013/892710 892710
4. Hernandez G., Bruhn A., Ince C., Microcirculation in sepsis: new perspectives. Current Vascular Pharmacology 2013 11 161 169
5. Skibsted S., Jones A. E., Puskarich M. A., Arnold R., Sherwin R., Trzeciak S., Schuetz P., Biomarkers of endothelial cell activation in early sepsis. Shock 2013 39 427 432
6. Landry D. W., Oliver J. A., The pathogenesis of vasodilatory shock. New England Journal of Medicine 2001 345 8 588 595 2-s2.0-0035940129 10.1056/NEJMra002709 (Pubitemid 32772102)
7. Davis J. S., Darcy C. J., Yeo T. W., Jones C., McNeil Y. R., Stephens D. P., Celermajer D. S., Anstey N. M., Asymmetric dimethylarginine, endothelial nitric oxide bioavailability and mortality in sepsis. PLoS ONE 2011 6 2 2-s2.0-79951972996 10.1371/journal.pone.0017260 e17260
8. Iapichino G., Umbrello M., Albicini M., Spanu P., Bellani G., Polli F., Pavlovic R., Cugno M., Fermo I., Paroni R., Time course of endogenous nitric oxide inhibitors in severe sepsis in humans. Minerva Anestesiologica 2010 76 5 325 333 2-s2.0-77954676829
9. Nijveldt R. J., Teerlink T., Van Der Hoven B., Siroen M. P. C., Kuik D. J., Rauwerda J. A., Van Leeuwen P. A. M., Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality. Clinical Nutrition 2003 22 1 23 30 2-s2.0-12244262222 10.1054/clnu.2002.0613 (Pubitemid 36193177)
10. O'Dwyer M. J., Dempsey F., Crowley V., Kelleher D. P., McManus R., Ryan T., Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study. Critical Care 2006 10 5, article R139 2-s2.0-34447628068 10.1186/cc5053 (Pubitemid 47086954)
11. Koch A., Weiskirchen R., Kunze J., Elevated asymmetric dimethylarginine levels predict short- and long-term mortality risk in critically ill patients. Journal of Critical Care. In press 10.1016/j.jcrc.2013.05.016
12. Mangoni A. A., Chapter 3 the emerging role of symmetric dimethylarginine in vascular disease. Advances in Clinical Chemistry 2009 48 73 94 2-s2.0-69449095139 10.1016/S0065-2423(09)48003-X
13. Leiper J., Vallance P., Biological significance of endogenous methylarginines that inhibit nitric oxide synthases. Cardiovascular Research 1999 43 3 542 548 2-s2.0-0033566683 10.1016/S0008-6363(99)00162-5 (Pubitemid 29369253)
14. Schwedhelm E., Böger R. H., The role of asymmetric and symmetric dimethylarginines in renal disease. Nature Reviews Nephrology 2011 7 5 275 285 2-s2.0-79955623424 10.1038/nrneph.2011.31
15. Bode-Böger S. M., Scalera F., Kielstein J. T., Martens-Lobenhoffer J., Breithardt G., Fobker M., Reinecke H., Symmetrical dimethylarginine: a new combined parameter for renal function and extent of coronary artery disease. Journal of the American Society of Nephrology 2006 17 4 1128 1134 2-s2.0-33645473328 10.1681/ASN.2005101119
16. Koch A., Gressner O. A., Sanson E., Tacke F., Trautwein C., Serum resistin levels in critically ill patients are associated with inflammation, organ dysfunction and metabolism and may predict survival of non-septic patients. Critical Care 2009 13 3, article R95 2-s2.0-67650608082 10.1186/cc7925
17. Koch A., Sanson E., Helm A., Voigt S., Trautwein C., Tacke F., Regulation and prognostic relevance of serum ghrelin concentrations in critical illness and sepsis. Critical Care 2010 14 3, article R94 2-s2.0-77952497875 10.1186/cc9029
18. Koch A., Weiskirchen R., Zimmermann H. W., Sanson E., Trautwein C., Tacke F., Relevance of serum leptin and leptin-receptor concentrations in critically ill patients. Mediators of Inflammation 2010 2010 9 2-s2.0-77957891117 10.1155/2010/473540 473540
19. Koch A., Voigt S., Kruschinski C., Sanson E., Dückers H., Horn A., Yagmur E., Zimmermann H., Trautwein C., Tacke F., Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients. Critical Care 2011 15 1, article R63 2-s2.0-79951557734 10.1186/cc10037
20. Backes Y., van der Sluijs K. F., Mackie D. P., Tacke F., Koch A., Tenhunen J. J., Schultz M. J., Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Medicine 2012 38 1418 1428
21. Böger R. H., Live and let die: asymmetric dimethylarginine and septic shock. Critical Care 2006 10 6, article 169 2-s2.0-34447624325 10.1186/cc5076 (Pubitemid 47087041)
22. Kielstein J. T., Böger R. H., Bode-Böger S. M., Schäffer J., Barbey M., Koch K. M., Frölich J. C., Asymmetric dimethylarginine plasma concentrations differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. Journal of the American Society of Nephrology 1999 10 3 594 600 2-s2.0-0344791653 (Pubitemid 29117641)
23. Ogawa T., Kimoto M., Watanabe H., Sasaoka K., Metabolism of NG,NG-and NG,N'G-dimethylarginine in rats. Archives of Biochemistry and Biophysics 1987 252 2 526 537 2-s2.0-0023164986
24. Kiechl S., Lee T., Santer P., Thompson G., Tsimikas S., Egger G., Holt D. W., Willeit J., Xu Q., Mayr M., Asymmetric and symmetric dimethylarginines are of similar predictive value for cardiovascular risk in the general population. Atherosclerosis 2009 205 1 261 265 2-s2.0-67349279132 10.1016/j.atherosclerosis. 2008.10.040
25. Leiper J., Nandi M., Torondel B., Murray-Rust J., Malaki M., O'Hara B., Rossiter S., Anthony S., Madhani M., Selwood D., Smith C., Wojciak-Stothard B., Rudiger A., Stidwill R., McDonald N. Q., Vallance P., Disruption of methylarginine metabolism impairs vascular homeostasis. Nature Medicine 2007 13 2 198 203 2-s2.0-33847005404 10.1038/nm1543